Evidence map›Paper›PMID 39811044›Full record

ArticleRevista panamericana de salud publica = Pan American journal of public health2025

[Pharmacovigilance of COVID-19 Vaccines in Brazil: Actions Taken, Lessons Learned, and Next StepsFarmacovigilancia de las vacunas contra la COVID-19 en Brasil: medidas adoptadas, enseñanzas extraídas y próximos pasos].

Roberta Mendes Abreu Silva, Cibelle Mendes Cabral, Jadher Percio, Martha Elizabeth Brasil da Nóbrega, Carla Dinamerica Kobayashi, Adriano Ferreira Martins, Felipe Daniel Cardoso, Victor Bertollo Gomes Porto, Leon Capovilla, Mônica Brauner de Moraes and 2 more

Abstract readCase ReportsEnglish Abstract
In one paragraph

Article in Revista panamericana de salud publica = Pan American journal of public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Roberta Mendes Abreu SilvaMinistério da Saúde Brasília-DF Brasil Ministério da Saúde, Brasília-DF, Brasil.
Cibelle Mendes CabralMinistério da Saúde Brasília-DF Brasil Ministério da Saúde, Brasília-DF, Brasil.
Jadher PercioMinistério da Saúde Brasília-DF Brasil Ministério da Saúde, Brasília-DF, Brasil.
Martha Elizabeth Brasil da NóbregaMinistério da Saúde Brasília-DF Brasil Ministério da Saúde, Brasília-DF, Brasil.
Carla Dinamerica KobayashiMinistério da Saúde Brasília-DF Brasil Ministério da Saúde, Brasília-DF, Brasil.
Adriano Ferreira MartinsMinistério da Saúde Brasília-DF Brasil Ministério da Saúde, Brasília-DF, Brasil.
Felipe Daniel CardosoMinistério da Saúde Brasília-DF Brasil Ministério da Saúde, Brasília-DF, Brasil.
Victor Bertollo Gomes PortoSecretaria de Saúde do Distrito Federal Brasília-DF Brasil Secretaria de Saúde do Distrito Federal, Brasília-DF, Brasil.
Leon CapovillaMinistério da Saúde Brasília-DF Brasil Ministério da Saúde, Brasília-DF, Brasil.
Mônica Brauner de MoraesMinistério da Saúde Brasília-DF Brasil Ministério da Saúde, Brasília-DF, Brasil.
Paulo Henrique Santos AndradeMinistério da Saúde Brasília-DF Brasil Ministério da Saúde, Brasília-DF, Brasil.
Eder Gatti FernandesMinistério da Saúde Brasília-DF Brasil Ministério da Saúde, Brasília-DF, Brasil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To document the actions taken by Brazil's National Immunization Program for the pharmacovigilance of COVID-19 vaccines. Methods: Documentary research on the period 2020 to 2023. Documentary sources from the national Ministry of Health during COVID-19 vaccination were used to analyze and interpret the actions taken. The analysis was split into two stages: preparation and operationalization. The publications were organized according to title, date of publication, description, and URL. Results: A total of 86 documents published during the preparation and operationalization of vaccination were found and evaluated. In the preparation phase, a technical advisory board on immunization was set up and specific technical notes were published for COVID-19 vaccines and the introduction of a new information system. In the operationalization stage, the Interinstitutional Committee for Pharmacovigilance of Vaccines and other Immunobiologicals was created. Also, hospital sentinel surveillance systems were established for adverse events of special interest, and surveillance of COVID-19 vaccination safety in pregnant women was implemented. Conclusion: Pharmacovigilance was strengthened in the context of COVID-19 vaccination in Brazil. Given the gaps in knowledge about the new vaccines, as well as the

Indexed as

BrazilCOVID-19 vaccinesimmunizationimmunization programspandemicspharmacovigilancesentinel surveillance

Identifiers

PMID39811044
PMCPMC11726120

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.